2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline

C126H126N40O2 — CID 158595852

IUPAC2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline
SMILESCc1cccc(-c2[nH]c(CNc3cccc(N(C)C)c3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3cccc(N4CCOCC4)c3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N(C)C)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N3CCCC3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N3CCOCC3)nc2-c2ccc3ncnn3c2)n1
InChIInChI=1S/2C26H26N8O.C26H26N8.2C24H24N8/c1-18-4-2-7-22(30-18)26-25(19-8-9-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-5-3-6-21(14-20)33-10-12-35-13-11-33;1-18-5-4-7-21(30-18)26-25(19-9-10-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-6-2-3-8-22(20)33-11-13-35-14-12-33;1-18-7-6-9-21(30-18)26-25(19-11-12-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-8-2-3-10-22(20)33-13-4-5-14-33;1-16-6-4-9-20(28-16)24-23(17-10-11-22-26-15-27-32(22)14-17)29-21(30-24)13-25-18-7-5-8-19(12-18)31(2)3;1-16-7-6-9-19(28-16)24-23(17-11-12-22-26-15-27-32(22)14-17)29-21(30-24)13-25-18-8-4-5-10-20(18)31(2)3/h2-9,14,16-17,27H,10-13,15H2,1H3,(H,31,32);2-10,16-17,27H,11-15H2,1H3,(H,31,32);2-3,6-12,16-17,27H,4-5,13-15H2,1H3,(H,31,32);2*4-12,14-15,25H,13H2,1-3H3,(H,29,30)
InChIKeyHVAAZHXETRKDIR-UHFFFAOYSA-N
MW2232.67 g/mol
LogP20.92
Rot. Bonds30

About 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline

2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline (PubChem CID 158595852) has the molecular formula C126H126N40O2 and a molecular weight of 2232.67 g/mol. Its IUPAC name is 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline.

Molecular Properties

Compound Name2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline
PubChem CID158595852
Molecular FormulaC126H126N40O2
Molecular Weight2232.67 g/mol
Exact Mass2231.10
IUPAC Name2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline
SMILESCc1cccc(-c2[nH]c(CNc3cccc(N(C)C)c3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3cccc(N4CCOCC4)c3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N(C)C)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N3CCCC3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N3CCOCC3)nc2-c2ccc3ncnn3c2)n1
InChIInChI=1S/2C26H26N8O.C26H26N8.2C24H24N8/c1-18-4-2-7-22(30-18)26-25(19-8-9-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-5-3-6-21(14-20)33-10-12-35-13-11-33;1-18-5-4-7-21(30-18)26-25(19-9-10-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-6-2-3-8-22(20)33-11-13-35-14-12-33;1-18-7-6-9-21(30-18)26-25(19-11-12-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-8-2-3-10-22(20)33-13-4-5-14-33;1-16-6-4-9-20(28-16)24-23(17-10-11-22-26-15-27-32(22)14-17)29-21(30-24)13-25-18-7-5-8-19(12-18)31(2)3;1-16-7-6-9-19(28-16)24-23(17-11-12-22-26-15-27-32(22)14-17)29-21(30-24)13-25-18-8-4-5-10-20(18)31(2)3/h2-9,14,16-17,27H,10-13,15H2,1H3,(H,31,32);2-10,16-17,27H,11-15H2,1H3,(H,31,32);2-3,6-12,16-17,27H,4-5,13-15H2,1H3,(H,31,32);2*4-12,14-15,25H,13H2,1-3H3,(H,29,30)
InChIKeyHVAAZHXETRKDIR-UHFFFAOYSA-N
XLogP20.92
TPSA453.61 Ų
H-Bond Donors10
H-Bond Acceptors37
Rotatable Bonds30
Heavy Atoms168
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002232.67
LogP ≤ 520.92
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1037

Analyze 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-fluoro-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-(morpholin-4-ylmethyl)aniline
CID 54767911
2-methoxy-N-[[5-[3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-2H-pyrazolo[3,4-b]pyridin-5-yl]-3-pyridinyl]methyl]ethanamine
CID 135497823
1-((1r,4r)-4-morpholinocyclohexyl)-3-(2-(pyridin-2-ylmethyl)-1H-benzo[d]imidazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
CID 44441730
US9266891, III-12
CID 76072012
(2S)-2-[[4-[4-[4-(5-benzylpyrimidin-2-yl)piperazin-1-yl]pyrrolo[2,1-f][1,2,4]triazin-6-yl]pyrazol-1-yl]methyl]morpholine
CID 118032959
US10544143, Example 362
CID 138686503
US10730877, Example 768
CID 138686357
US10544143, Example 75
CID 138686399
US10544143, Example 736
CID 138686577
US10730877, Example 779
CID 138686683
US10730877, Example 771
CID 138686743
US10730877, Example 782
CID 138686813

Frequently Asked Questions

What is the IUPAC name of 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline?
The IUPAC name of 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline (CID 158595852) is 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline.
What is the SMILES notation for 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline?
The canonical SMILES for 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline is Cc1cccc(-c2[nH]c(CNc3cccc(N(C)C)c3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3cccc(N4CCOCC4)c3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N(C)C)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N3CCCC3)nc2-c2ccc3ncnn3c2)n1.Cc1cccc(-c2[nH]c(CNc3ccccc3N3CCOCC3)nc2-c2ccc3ncnn3c2)n1.
What is the InChIKey of 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline?
The InChIKey is HVAAZHXETRKDIR-UHFFFAOYSA-N. The full InChI is InChI=1S/2C26H26N8O.C26H26N8.2C24H24N8/c1-18-4-2-7-22(30-18)26-25(19-8-9-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-5-3-6-21(14-20)33-10-12-35-13-11-33;1-18-5-4-7-21(30-18)26-25(19-9-10-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-6-2-3-8-22(20)33-11-13-35-14-12-33;1-18-7-6-9-21(30-18)26-25(19-11-12-24-28-17-29-34(24)16-19)31-23(32-26)15-27-20-8-2-3-10-22(20)33-13-4-5-14-33;1-16-6-4-9-20(28-16)24-23(17-10-11-22-26-15-27-32(22)14-17)29-21(30-24)13-25-18-7-5-8-19(12-18)31(2)3;1-16-7-6-9-19(28-16)24-23(17-11-12-22-26-15-27-32(22)14-17)29-21(30-24)13-25-18-8-4-5-10-20(18)31(2)3/h2-9,14,16-17,27H,10-13,15H2,1H3,(H,31,32);2-10,16-17,27H,11-15H2,1H3,(H,31,32);2-3,6-12,16-17,27H,4-5,13-15H2,1H3,(H,31,32);2*4-12,14-15,25H,13H2,1-3H3,(H,29,30).
What are the key properties of 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline?
2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline has a molecular weight of 2232.67 g/mol, XLogP of 20.92, 30 rotatable bonds, 10 hydrogen bond donors, and 37 hydrogen bond acceptors.
Where does this data come from?
All data for 2-N,2-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,2-diamine;3-N,3-N-dimethyl-1-N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]benzene-1,3-diamine;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-3-morpholin-4-ylaniline;N-[[5-(6-methyl-2-pyridinyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]-2-pyrrolidin-1-ylaniline is sourced from PubChem (CID 158595852), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).